Cholangiocarcinoma represents a diverse group of epithelial cancers united by late
diagnosis and poor outcomes. Specific diagnostic and therapeutic approaches are …

Pancreatic cancer is the fourth most common cause of cancer-related deaths in the United
States, with over 38000 deaths in 2013. The opportunity to detect pancreatic cancer while it …

Cholangiocarcinoma (CCA) comprises a heterogeneous group of cancers with pathologic
features of biliary tract differentiation, and is presumed to arise from the intra-or extrahepatic …

Abstract Background Biliary tract cancers (BTCs) include intrahepatic (IHC), hilar, distal bile
duct (DBD) and gallbladder carcinoma (GBC). Neutrophil/lymphocyte ratio (NLR), a marker …

Background & Aims Acute pancreatitis (AP) is often the initial presentation of pancreatic
cancer (pancreatic adenocarcinoma [PaCa]). We evaluated the risk of PaCa after AP …

The association between tumor size and survival in patients with intrahepatic
cholangiocarcinoma (ICC) undergoing surgical resection is controversial. We sought to …

Purpose To compare the diagnostic performance of the noncontrast MRI including DWI to
the standard MRI for detecting hepatic malignancies in patients with chronic liver disease …

OBJECTIVES: Patients with pancreatic cancer (PaCa) sometimes present with symptoms
suggestive of chronic pancreatitis (CP). We evaluated the prevalence of undiagnosed PaCa …

Intrahepatic cholangiocarcinoma (ICC) accounts for up to 15% of primary liver cancer cases
and is the second most common primary hepatic malignancy after hepatocellular carcinoma …

Intrahepatic cholangiocarcinoma is an aggressive malignancy and is one of the most
devastating cancers of the gastrointestinal tract. The molecular mechanisms contributing to …